AKT1 and cancer: Interaction with the CXCR1/CXCR2 receptor activates three molecular pathways: PI3K/Akt, the mitogen-activated protein kinase (MAPK) cascade, and FAK/Src, which confer chemoresistance to cancer cells [8,9,10].